1 - 21 of 21

Beverly L. Davidson, PhD

Photo of Beverly L. Davidson, PhD

Dr. Davidson works to understand the molecular basis of childhood onset neurodegenerative diseases and the development of gene and small molecule therapies for treatment. She also focuses on how noncoding RNAs participate in neural development and neurodegenerative disease processes, and how they can be harnessed for therapies.


Diva D. De León-Crutchlow, MD, MSCE

Diva D. De León-Crutchlow

Dr. De Leon-Crutchlow’s translational research program focuses on examining the pathophysiology of disorders of insulin regulation, identifying novel therapeutic targets, and developing new therapies for these conditions. The program approach includes patient-oriented research and bench research employing mouse models and primary islet cultures.


Thomas De Raedt, PhD

Thomas De Raedt

Dr. De Raedt researches pediatric high grade glioma development and aims to understand the involvement of crucial pathways. He investigates pathway interaction, and explores ways to develop therapies through analyzing human tumors, performing cellular studies, and developing accurate mouse models. This allows Dr. De Raedt and his team to perform novel pre-clinical studies that can lead to clinical trials.


Matthew A. Deardorff , MD, PhD

Photo of Matthew A. Deardorff

Dr. Deardorff’s work integrates patient information with genomics and cell biology to diagnosis and understand rare genetic disease.  His research focuses on disorders caused by dysregulation of chromatin or altered translational regulation, specifically, Cornelia de Lange, Coffin-Siris, Skraban-Deardorff and KBG syndromes.


Andrew Degnan, MD, MPhil

Andrew Degnan, MD, MPhil

Dr. Degnan's research and clinical training has focused on the development and application of imaging approaches to advance patient care through accurate diagnosis and improved prognostication.


Sara B. DeMauro, MD, MSCE

Sara B. DeMauro, MD, MSCE

Dr. DeMauro has special expertise in rigorous assessment of early childhood outcomes of high-risk neonates. Her research focuses on improving outcomes of children with bronchopulmonary dysplasia and school-age assessment of functional outcomes in preterm-born children.


Sharon J. Diskin, PhD

Sharon J. Diskin

Dr. Diskin's research is focused on translational genomics in childhood cancers. Her laboratory seeks to identify the genetic basis of childhood cancers by combining quantitative computational methods with rigorous "wet-lab" experimental approaches. In parallel, she has developed, and is applying, a proteogenomic approach to identify novel immunotherapeutic targets for high-risk and relapsed pediatric malignancies.


Dennis Dlugos, MD, MSCE

Dennis Dlugos

Dr. Dlugos is the director of the Section of Clinical Neurophysiology at Children’s Hospital of Philadelphia. He studies epilepsy genetics, pharmacogenetics, and epilepsy surgery. He is also a core faculty member of the ENGIN Frontier Program.


Yoav Dori, MD, PhD

Yoav Dori

Dr. Dori is a pediatric cardiologist and director of Pediatric Lymphatic Imaging and Interventions and Lymphatic Research.


Steven D. Douglas, MD

Steven D. Douglas

Dr. Douglas has extensive laboratory experience investigating the cellular immunology of HIV/AIDS, primary immune deficiency diseases, and cellular immunopathologies. In addition, he has had significant involvement in studies related to immunological interactions.


Stephanie K. Doupnik, MD, MS

Stephanie K. Doupnik

Dr. Doupnik’s research investigates how to ensure that children can access effective mental health services. She uses methods from diverse fields, including epidemiology, comparative effectiveness, and health policy research. Currently, she is focused on suicide prevention and integration of mental health services into children’s hospitals.


Kevin Downes, MD

Kevin Downes

The research interests of Dr. Downes focus on antimicrobial clinical pharmacology and pharmacoepidemiology in children with a goal to identify novel approaches to optimize efficacy, minimize toxicity, and limit antimicrobial resistance from antibiotics.


Nadia L. Dowshen, MD, MSHP

Nadia L. Dowshen

Dr. Dowshen focuses on improving the health outcomes for adolescent and young adults (AYA) living with or at high risk for contracting HIV/AIDS and improving access and quality of care for gender expansive and transgender children and adolescents. She is particularly interested in developing and testing digital health interventions to reach, engage, and retain AYA in care.